Table of Contents
Executive Summary
-
- The market
-
- Figure 1: Best- and worst-case forecast for UK value sales of OTC analgesics, 2009-19
- Market drivers
- Companies, brands and innovation
-
- Figure 2: New product launches in the OTC analgesics category, by format type, January 2010-March 2014
- Consumers typically rely on oral remedies to treat pain
-
- Figure 3: Types of medication used, April 2014
- A quarter of consumers always buy own-label analgesics
-
- Figure 4: Purchase considerations when buying OTC pain relief, April 2014
- Nearly two in five concerned that painkillers only mask the pain
-
- Figure 5: Attitudes towards pain relief remedies, April 2014
- Consumers interested in faster working remedies
-
- Figure 6: Factors influencing change, April 2014
- What we think
Issues and Insights
-
- Opportunity to expand product innovation for headache relief
- The facts
- The implications
- Bolstering usage of OTC analgesics amongst men
- The facts
- The implications
- Combination packs could help offer stronger pain relief
- The facts
- The implications
Trend Application
-
- Trend: Factory Fear
- Trend: FSTR HYPR
- Trend: Return to the Experts
Market Drivers
-
- Key points
- Population changes
-
- Figure 7: Trends in the age structure of the UK population, 2008-18
- Rising number of prescriptions presents challenge to OTC market
-
- Figure 8: Number of prescriptions per person, UK, 2006-12
- Increasing workforce creates potential opportunities for brands
-
- Figure 9: Employment and unemployment, by gender, 2008-18
Who’s Innovating?
-
- Key points
- Launch activity up in 2013
-
- Figure 10: New product launches in the OTC analgesics category, by launch type, January 2010-March 2014
- Branded vs own-label launches
-
- Figure 11: New product launches in the OTC analgesics category, branded vs own-label, January 2010-March 2014
-
- Figure 12: Examples of own-label OTC analgesics launched in the UK, 2013-14
- Growth in non-ingested remedies
-
- Figure 13: New product launches in the OTC analgesics category, by format type, January 2010-March 2014
-
- Figure 14: Examples of branded non-ingested analgesics launched in the UK, 2013
- Figure 15: Examples of own-label analgesics in tablets/capsules form launched in the UK, 2013
- Launch activity remains fragmented
-
- Figure 16: New product launches in the OTC analgesics category, by company, 2013
- Figure 17: Examples of OTC analgesics launched by Aldi and Wilkinson, 2013
-
- Figure 18: Examples of OTC analgesics launched by Tesco, 2013-14
- Time/speed continues to be an important claim in 2013
-
- Figure 19: New product launches in the OTC analgesics category, by top 10 claims, 2013
- Scope to expand herbal/botanical claims
- Just 3% of new launches carry ‘on-the-go’ claims
-
- Figure 20: Examples of OTC analgesics carrying ‘on-the-go’ claims, 2013
Market Size and Forecast
-
- Key points
- Significant rise in value sales in 2013
-
- Figure 21: UK value sales for OTC analgesics, 2009-19
- Fan chart
-
- Figure 22: Best- and worst-case forecast for UK value sales of OTC analgesics, 2009-19
- Forecast methodology
Segment Performance
-
- Key points
- Segment overview and comparison
-
- Figure 23: Consumer spending on OTC analgesics, by segment, year ending April 2013-14
Market Share
-
- Key points
- Adult oral remedies
-
- Figure 24: Value sales of top oral analgesics brands, year ending February 2013-14
- Voltarol drives topical treatments sales
-
- Figure 25: Value sales of top topical treatment brands, year ending February, 2013-14
- Sales decline seen across children’s analgesics brands
-
- Figure 26: Value sales of top children’s analgesics brands, year ending February 2013-14
- Bonjela loses share to smaller brands
-
- Figure 27: Value sales of top oral lesions and toothache analgesics brands, year ending February 2013-14
Companies and Products
-
- Reckitt Benckiser
-
- Figure 28: Reckitt Benckiser (global) financial performance, 2011-12
-
- Figure 29: Examples of new product launches by Reckitt Benckiser in the Analgesics market, 2013-14
- GlaxoSmithKline
-
- Figure 30: GlaxoSmithKline UK Limited financial performance, 2011-12
- Pfizer
-
- Figure 31: Pfizer Consumer Healthcare Limited financial performance, 2011-12
- Novartis
-
- Figure 32: Novartis Consumer Health UK Limited financial performance, 2011-12
- Johnson & Johnson (McNeil Products)
-
- Figure 33: McNeil Healthcare (UK) Limited financial performance, 2011-12
Brand Research
-
- Brand map
-
- Figure 34: Attitudes towards and usage of brands in the analgesics sector, March 2014
- Correspondence analysis
- Brand attitudes
-
- Figure 35: Attitudes, by analgesics brand, March 2014
- Brand personality
-
- Figure 36: Analgesics brand personality – Macro image, March 2014
-
- Figure 37: Analgesics brand personality – Micro image, March 2014
- Brand experience
-
- Figure 38: Analgesics brand usage, March 2014
-
- Figure 39: Satisfaction with various analgesics brands, March 2014
-
- Figure 40: Consideration of analgesics brands, March 2014
-
- Figure 41: Consumer perceptions of current analgesics brand performance, March 2014
- Brand recommendation
-
- Figure 42: Recommendation of selected analgesics brands, March 2014
Brand Communication and Promotion
-
- Key points
- Adspend up in 2013
-
- Figure 43: Main media advertising expenditure on OTC analgesics, January 2010-March 2014
- Novartis and Reckitt Benckiser sustain battle for number one advertising position
-
- Figure 44: Main media advertising expenditure on OTC analgesics, by selected advertisers, January 2010-March 2014
- Voltarol the biggest spender on advertising in the analgesics market
-
- Figure 45: Main media advertising expenditure on OTC analgesics, by advertiser and brand, 2013
- Brands could look to shift into other media channels
-
- Figure 46: Main media advertising expenditure on OTC analgesics, % by media type, January 2010-March 2014
Channels to Market
-
- Key points
- Supermarkets the main distribution channel for analgesics
-
- Figure 47: Distribution of OTC analgesics, 2011-13
The Consumer – Pains Experienced and Treatments Sought
-
- Key points
- Three in five have suffered from a headache
-
- Figure 48: Pain experienced, April 2014
- Younger consumers present new opportunities for analgesics brands
- Women more likely to experience pain than men
-
- Figure 49: Pain experienced, April 2014
- Preferred remedy formats
-
- Figure 50: Types of medication used, April 2014
- Topical remedies used by a third of pain sufferers
- Men prefer topical remedies
-
- Figure 51: Types of medication used, April 2014
- Specific remedies used
-
- Figure 52: Specific analgesics used, April 2014
The Consumer – Purchase Considerations
-
- Key points
- A quarter of consumers always buy own-label analgesics
-
- Figure 53: Purchase considerations when buying OTC pain relief remedies, April 2014
- Men more likely to buy branded products
-
- Figure 54: Purchase considerations when buying OTC analgesics, April 2014
- Consumers more loyal to brands when it comes to topical treatments
-
- Figure 55: Purchase considerations when buying OTC pain relief capsules/tablets, April 2014
The Consumer – Motives for Trying a New Product
-
- Key points
- Consumers interested in faster working remedies
-
- Figure 56: Factors influencing change, April 2014
- Recommendations drive new product usage
-
- Figure 57: Proportion of consumers who agreed that they would try a new product if it was recommended by their doctor/pharmacist or a friend/family member, by gender and age, April 2014
- Natural products resonate with nearly one in five
The Consumer – Attitudes Towards Pain Relief Remedies
-
- Key points
- Nearly two in five concerned that painkillers only mask pain
-
- Figure 58: Attitudes towards pain relief remedies, April 2014
- Joint pain sufferers seek alternative pain management methods
-
- Figure 59: Agreement with selected statements, by type of pain experienced (all pain and selected pains), April 2014
- Younger consumers worry about reliance on analgesics
-
- Figure 60: Attitudes towards using OTC analgesics, by age, April 2014
Appendix – Who’s Innovating?
-
-
- Figure 61: Launches by format type, by branded/own-label, 2013
- Figure 62: Top 10 claims, January 2009-March 2014
- Figure 63: Launch activity, by top 10 companies, January 2009-March 2014
- Figure 64: Launch activity, by company, 2013
-
Appendix – Market Size and Forecast
-
-
- Figure 65: Value sales for adult oral analgesics, 2009-19
- Figure 66: Value sales for paediatric analgesics, 2009-19
- Figure 67: Value sales for topical analgesics, 2009-19
-
Appendix – Brand Research
-
-
- Figure 68: Brand usage, March 2014
- Figure 69: Brand commitment, March 2014
-
- Figure 70: Brand momentum, March 2014
- Figure 71: Brand diversity, March 2014
-
- Figure 72: Brand satisfaction, March 2014
- Figure 73: Brand recommendation, March 2014
-
- Figure 74: Brand attitude, March 2014
- Figure 75: Brand image – Macro image, March 2014
-
- Figure 76: Brand image – Micro image, March 2014
-
Appendix – Brand Communication and Promotion
-
-
- Figure 77: Main media advertising expenditure on OTC analgesics, by selected advertisers, January 2010-March 2014
- Figure 78: Main media advertising expenditure on OTC analgesics, by media type, January 2010-March 2014
-
Appendix – The Consumer – Pains Experienced and Treatments Sought
-
-
- Figure 79: Pain experienced, April 2014
-
- Figure 80: Most popular pain experienced, by demographics, April 2014
-
- Figure 81: Next most popular pain experienced, by demographics, April 2014
-
- Figure 82: Other pain experienced, by demographics, April 2014
-
- Figure 83: Types of medication used, April 2014
-
- Figure 84: Types of medication used, by demographics, April 2014
-
- Figure 85: Specific analgesics used, April 2014
-
- Figure 86: Most popular specific analgesics used, by demographics, April 2014
-
- Figure 87: Next most popular specific analgesics used, by demographics, April 2014
-
- Figure 88: Types of medication used, by most popular pain experienced, April 2014
-
- Figure 89: Types of medication used, by next most popular pain experienced, April 2014
-
- Figure 90: Specific analgesics used, by most popular pain experienced, April 2014
-
- Figure 91: Specific analgesics used, by next most popular pain experienced, April 2014
-
- Figure 92: Types of medication used, by types of medication used, April 2014
-
- Figure 93: Specific analgesics used, by specific analgesics used, April 2014
-
- Figure 94: Specific analgesics used, by specific analgesics used, April 2014
-
- Figure 95: Specific analgesics used, by next most popular pain experienced, April 2014
-
Appendix – The Consumer – Purchase Considerations
-
-
- Figure 96: Attitudes and behaviours relating to choosing analgesics, April 2014
-
- Figure 97: Most popular attitudes and behaviours relating to choosing analgesics – Any, by demographics, April 2014
-
- Figure 98: Next most popular attitudes and behaviours relating to choosing analgesics – Any, by demographics, April 2014
-
Appendix – The Consumer – Motivations for Trying a New Product
-
-
- Figure 99: Factors influencing change, April 2014
-
- Figure 100: Most popular factors influencing change, by demographics, April 2014
-
- Figure 101: Next most popular factors influencing change, by demographics, April 2014
-
- Figure 102: Factors influencing change, by types of medication used, April 2014
-
Appendix – The Consumer – Attitudes Towards Pain Relief Remedies
-
-
- Figure 103: Attitudes towards pain relief remedies, April 2014
-
- Figure 104: Most popular attitudes towards pain relief remedies, by demographics, April 2014
-
- Figure 105: Next most popular attitudes towards pain relief remedies, by demographics, April 2014
-
- Figure 106: Attitudes towards pain relief remedies, by most popular pain experienced, April 2014
-
- Figure 107: Attitudes towards pain relief remedies, by next most popular pain experienced, April 2014
-
Appendix – Demographic Overview
-
-
- Figure 108: Gender of respondents, by age, April 2014
- Figure 109: Gender of respondents, by age of children present in their own household, April 2014
-
- Figure 110: Financial situation of respondents, by gender and age, April 2014
- Figure 111: Working status of respondents, by age, April 2014
-
Back to top